Review





Similar Products

96
Gatan Inc tsl oim analysis 5 2 software package
Tsl Oim Analysis 5 2 Software Package, supplied by Gatan Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tsl oim analysis 5 2 software package/product/Gatan Inc
Average 96 stars, based on 1 article reviews
tsl oim analysis 5 2 software package - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

99
Malvern Panalytical peaq itc analysis software package
Peaq Itc Analysis Software Package, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peaq itc analysis software package/product/Malvern Panalytical
Average 99 stars, based on 1 article reviews
peaq itc analysis software package - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

96
Gatan Inc oim analysis software package version 8 0
Oim Analysis Software Package Version 8 0, supplied by Gatan Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oim analysis software package version 8 0/product/Gatan Inc
Average 96 stars, based on 1 article reviews
oim analysis software package version 8 0 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

99
Sartorius AG incucyte zoom software package
Incucyte Zoom Software Package, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/incucyte zoom software package/product/Sartorius AG
Average 99 stars, based on 1 article reviews
incucyte zoom software package - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
Sartorius AG incucyte software package
Incucyte Software Package, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/incucyte software package/product/Sartorius AG
Average 99 stars, based on 1 article reviews
incucyte software package - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
SAS institute one-way anova statistical analysis systems statistical software package
One Way Anova Statistical Analysis Systems Statistical Software Package, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/one-way anova statistical analysis systems statistical software package/product/SAS institute
Average 90 stars, based on 1 article reviews
one-way anova statistical analysis systems statistical software package - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Gatan Inc oim analysis 8 6 software packages
Oim Analysis 8 6 Software Packages, supplied by Gatan Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oim analysis 8 6 software packages/product/Gatan Inc
Average 96 stars, based on 1 article reviews
oim analysis 8 6 software packages - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

98
LI-COR odyssey software package
Odyssey Software Package, supplied by LI-COR, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/odyssey software package/product/LI-COR
Average 98 stars, based on 1 article reviews
odyssey software package - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

99
Sartorius AG incucyte angiogenesis software package
A and B , Bioluminescence of HEK-293T VEGFR reporter cells treated with supernatant containing either anti-VEGF or anti-CD19 and recombinant VEGF (rVEGF) (Data from technical triplicates, points represent the mean, error bars represent SEM, p-value by two-way ANOVA) ( A ) or supernatant from confluent VEGF-producing 786O tumor cells (data from technical triplicates, lines represent the median, p-value by one-way ANOVA) ( B ). C, Schematic of in vitro <t>angiogenesis</t> assay to visualize blood vessel formation upon blocking VEGF. GFP + human umbilical vein endothelial cells (HUVECs) were cocultured with normal human dermal fibroblasts (NHDFs), suramin, rVEGF, and culture supernatant from CAR αCD19 or CAR αVEGF constructs and primitive blood vessel formation was imaged over time on the <t>incucyte.</t> D, Representative images of GFP + HUVECs with vessels labeled by the automated incucyte angiogenesis software package. E, HUVEC blood vessel network length (length of blood vessel network (mm) per mm 2 in image). (data representative of 2 technical replicates, mean±SEM, p-value by two-way ANOVA).
Incucyte Angiogenesis Software Package, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/incucyte angiogenesis software package/product/Sartorius AG
Average 99 stars, based on 1 article reviews
incucyte angiogenesis software package - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
Sartorius AG octet bli analysis 12 2 2 4 software package
A and B , Bioluminescence of HEK-293T VEGFR reporter cells treated with supernatant containing either anti-VEGF or anti-CD19 and recombinant VEGF (rVEGF) (Data from technical triplicates, points represent the mean, error bars represent SEM, p-value by two-way ANOVA) ( A ) or supernatant from confluent VEGF-producing 786O tumor cells (data from technical triplicates, lines represent the median, p-value by one-way ANOVA) ( B ). C, Schematic of in vitro <t>angiogenesis</t> assay to visualize blood vessel formation upon blocking VEGF. GFP + human umbilical vein endothelial cells (HUVECs) were cocultured with normal human dermal fibroblasts (NHDFs), suramin, rVEGF, and culture supernatant from CAR αCD19 or CAR αVEGF constructs and primitive blood vessel formation was imaged over time on the <t>incucyte.</t> D, Representative images of GFP + HUVECs with vessels labeled by the automated incucyte angiogenesis software package. E, HUVEC blood vessel network length (length of blood vessel network (mm) per mm 2 in image). (data representative of 2 technical replicates, mean±SEM, p-value by two-way ANOVA).
Octet Bli Analysis 12 2 2 4 Software Package, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/octet bli analysis 12 2 2 4 software package/product/Sartorius AG
Average 99 stars, based on 1 article reviews
octet bli analysis 12 2 2 4 software package - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

Image Search Results


A and B , Bioluminescence of HEK-293T VEGFR reporter cells treated with supernatant containing either anti-VEGF or anti-CD19 and recombinant VEGF (rVEGF) (Data from technical triplicates, points represent the mean, error bars represent SEM, p-value by two-way ANOVA) ( A ) or supernatant from confluent VEGF-producing 786O tumor cells (data from technical triplicates, lines represent the median, p-value by one-way ANOVA) ( B ). C, Schematic of in vitro angiogenesis assay to visualize blood vessel formation upon blocking VEGF. GFP + human umbilical vein endothelial cells (HUVECs) were cocultured with normal human dermal fibroblasts (NHDFs), suramin, rVEGF, and culture supernatant from CAR αCD19 or CAR αVEGF constructs and primitive blood vessel formation was imaged over time on the incucyte. D, Representative images of GFP + HUVECs with vessels labeled by the automated incucyte angiogenesis software package. E, HUVEC blood vessel network length (length of blood vessel network (mm) per mm 2 in image). (data representative of 2 technical replicates, mean±SEM, p-value by two-way ANOVA).

Journal: Cancer immunology research

Article Title: Secretion of a VEGF-blocking scFv enhances CAR T-cell potency

doi: 10.1158/2326-6066.CIR-24-0876

Figure Lengend Snippet: A and B , Bioluminescence of HEK-293T VEGFR reporter cells treated with supernatant containing either anti-VEGF or anti-CD19 and recombinant VEGF (rVEGF) (Data from technical triplicates, points represent the mean, error bars represent SEM, p-value by two-way ANOVA) ( A ) or supernatant from confluent VEGF-producing 786O tumor cells (data from technical triplicates, lines represent the median, p-value by one-way ANOVA) ( B ). C, Schematic of in vitro angiogenesis assay to visualize blood vessel formation upon blocking VEGF. GFP + human umbilical vein endothelial cells (HUVECs) were cocultured with normal human dermal fibroblasts (NHDFs), suramin, rVEGF, and culture supernatant from CAR αCD19 or CAR αVEGF constructs and primitive blood vessel formation was imaged over time on the incucyte. D, Representative images of GFP + HUVECs with vessels labeled by the automated incucyte angiogenesis software package. E, HUVEC blood vessel network length (length of blood vessel network (mm) per mm 2 in image). (data representative of 2 technical replicates, mean±SEM, p-value by two-way ANOVA).

Article Snippet: The assay was imaged and analyzed using the Sartorius Incucyte Angiogenesis Software package every 6 hours for 14 days.

Techniques: In Vitro, Recombinant, Angiogenesis Assay, Blocking Assay, Construct, Labeling, Software

A, CD69 surface expression of meso-targeting CAR T-cell constructs cultured with SKOV3 for 18 hours. B, CD69 surface expression of CD70-targeting CAR T-cell constructs cultured with plate bound CD70 antigen for 24 hours. C, 70 αVEGF and 70 αCD19 CAR T cells (n=4 donor T cells each) were incubated for 48 hours on plates coated with recombinant CD70 protein, then lysed and evaluated via targeted RNA expression. Heatmap results highlight individual pathway scores for each donor and construct. See supplemental figure 5 for additional details. D, Pathway score for the most differentially scored pathway from 3C. Symbols represent individual T-cell donors. Dashed line represents the median and the dotted line represents the top and bottom quartiles. All pathways were subjected to paired t tests and corrected for multiple comparisons with the two-stage step-up method of Bejanmini, Kreiger, and Yekutieli with a desired FDR (q) of 1%. E, Fold expansion of Meso αCD19 and meso αVEGF CAR-T cells from restimulation assays with meso + K562 ( 2 NDs and 2 technical replicates, mean±SEM, p-values by 2 way ANOVA). F and G, Cytotoxicity and proliferation of meso-targeting CAR T cells cultured with SKOV3 at 3:1 E:T ratio (2 NDs with 2+ technical replicates) ( F ) and OVCAR3 at 3:1 E:T (2 NDs) ( G ). H and I, Concentration of VEGF, IFNγ, TNFα, and Granzyme B in supernatant taken from endpoint of associated cytotoxicity assay, SKOV3 ( H ) and OVCAR3 ( I ) measured using Ella automated immunoassay system ( 2 ND with 2+ technical replicates). J and K, Cytotoxicity and proliferation of meso-targeting CAR T cells cultured with Nomo-1 at 3:1 E:T (1 ND, representative of 2 NDs) ( J ) and A549 at 3:1 E:T (2 NDs) ( K ), images depict GFP-expressing tumor and mcherry-expressing CAR T cells from the same respective wells at time 0 and after 72 hours of co-culture. L , M , and N, Cytotoxicity assays of mcherry+ CD70 αCD19 and CD70 αVEGF CAR T cells cultured with GFP + 786O at 2:1 E:T (3 NDs) ( L ), SKOV3 at 3:1 E:T ( 2 NDs) ( M ), and Nomo-1 at 3:1 E:T (1 ND) ( N ). O, Concentration of VEGF from supernatant of cytotoxicity assay in N (2 NDs with 2+ technical replicates). Cytotoxicity assays were performed using incucyte imaging system and wells were imaged every 1–2 hours. Data represents values normalized to the starting condition of red or green fluorescence. All cytotoxicity assays show mean±SEM with p-values by two-way ANOVA. All cytokine assays show mean±SEM with p-values by one-way ANOVA. ND-normal donor.

Journal: Cancer immunology research

Article Title: Secretion of a VEGF-blocking scFv enhances CAR T-cell potency

doi: 10.1158/2326-6066.CIR-24-0876

Figure Lengend Snippet: A, CD69 surface expression of meso-targeting CAR T-cell constructs cultured with SKOV3 for 18 hours. B, CD69 surface expression of CD70-targeting CAR T-cell constructs cultured with plate bound CD70 antigen for 24 hours. C, 70 αVEGF and 70 αCD19 CAR T cells (n=4 donor T cells each) were incubated for 48 hours on plates coated with recombinant CD70 protein, then lysed and evaluated via targeted RNA expression. Heatmap results highlight individual pathway scores for each donor and construct. See supplemental figure 5 for additional details. D, Pathway score for the most differentially scored pathway from 3C. Symbols represent individual T-cell donors. Dashed line represents the median and the dotted line represents the top and bottom quartiles. All pathways were subjected to paired t tests and corrected for multiple comparisons with the two-stage step-up method of Bejanmini, Kreiger, and Yekutieli with a desired FDR (q) of 1%. E, Fold expansion of Meso αCD19 and meso αVEGF CAR-T cells from restimulation assays with meso + K562 ( 2 NDs and 2 technical replicates, mean±SEM, p-values by 2 way ANOVA). F and G, Cytotoxicity and proliferation of meso-targeting CAR T cells cultured with SKOV3 at 3:1 E:T ratio (2 NDs with 2+ technical replicates) ( F ) and OVCAR3 at 3:1 E:T (2 NDs) ( G ). H and I, Concentration of VEGF, IFNγ, TNFα, and Granzyme B in supernatant taken from endpoint of associated cytotoxicity assay, SKOV3 ( H ) and OVCAR3 ( I ) measured using Ella automated immunoassay system ( 2 ND with 2+ technical replicates). J and K, Cytotoxicity and proliferation of meso-targeting CAR T cells cultured with Nomo-1 at 3:1 E:T (1 ND, representative of 2 NDs) ( J ) and A549 at 3:1 E:T (2 NDs) ( K ), images depict GFP-expressing tumor and mcherry-expressing CAR T cells from the same respective wells at time 0 and after 72 hours of co-culture. L , M , and N, Cytotoxicity assays of mcherry+ CD70 αCD19 and CD70 αVEGF CAR T cells cultured with GFP + 786O at 2:1 E:T (3 NDs) ( L ), SKOV3 at 3:1 E:T ( 2 NDs) ( M ), and Nomo-1 at 3:1 E:T (1 ND) ( N ). O, Concentration of VEGF from supernatant of cytotoxicity assay in N (2 NDs with 2+ technical replicates). Cytotoxicity assays were performed using incucyte imaging system and wells were imaged every 1–2 hours. Data represents values normalized to the starting condition of red or green fluorescence. All cytotoxicity assays show mean±SEM with p-values by two-way ANOVA. All cytokine assays show mean±SEM with p-values by one-way ANOVA. ND-normal donor.

Article Snippet: The assay was imaged and analyzed using the Sartorius Incucyte Angiogenesis Software package every 6 hours for 14 days.

Techniques: In Vitro, Expressing, Construct, Cell Culture, Incubation, Recombinant, RNA Expression, Concentration Assay, Cytotoxicity Assay, Co-Culture Assay, Imaging, Fluorescence